Filing Details

Accession Number:
0001140361-25-013253
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-10 16:07:53
Reporting Period:
2025-04-09
Filing Date:
2025-04-10
Accepted Time:
2025-04-10 16:07:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1281895 Rocket Pharmaceuticals Inc. RCKT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1725929 Kinnari Patel C/O Rocket Pharmaceuticals, Inc.
9 Cedarbrook Drive
Cranbury NJ 08512
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-09 21,099 $4.70 26,774 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 444,103 Direct
Common Stock 104,927 Indirect By Adaptive Technology LLC
Footnotes
  1. On April 9, 2025, the Reporting Person's husband purchased 21,099 shares of Common Stock in a series of brokered transactions at prices ranging from $4.65 to $4.78 and a weighted average price per share of $4.70 (rounded to two decimal places), for an aggregate purchase price of approximately $99,157. The detailed breakdown of executed sales will be furnished upon request.
  2. Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  3. The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.